EFFECTS OF IRON, RIBOFLAVIN AND IODIDE DEFICIENCIES ON HEPATIC DRUG-METABOLIZING ENZYME SYSTEMS

被引：0

作者：

CATZ, CS

JUCHAU, MR

YAFFE, SJ

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：197 / &

共 32 条

[1] AXELROD J, 1954, J PHARMACOL EXP THER, V111, P176
[2] BESSEY OA, 1949, J BIOL CHEM, V180, P755
[3] BRUNK SF, 1969, FED PROC, V28, P676
[4] METABOLIC INTERACTIONS BETWEEN L-ASCORBIC ACID AND DRUGS
CONNEY, AH
BRAY, GA
BURNS, JJ
EVANS, C
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1961, 92 (01) : 115 - &
[5] COOPER JR, 1955, J PHARMACOL EXP THER, V114, P409
[6] DALLMAN PR, 1968, J NUTR, V97, P475
[7] DEGKWITZ VE, 1968, HOPPESEYLERS Z PHYSI, V349, P465
[8] IMPAIRMENT OF HEPATIC DRUG METABOLISM IN CALCIUM DEFICIENCY
DINGELL, JV
JOINER, PD
HURWITZ, L
[J]. BIOCHEMICAL PHARMACOLOGY, 1966, 15 (07) : 971 - &
[9] DIXON RL, 1963, J PHARMACOL EXP THER, V142, P312
[10] DOXON RL, 1960, P SOC EXP BIOL MED, V103, P333